183 related articles for article (PubMed ID: 16313361)
1. Induction and recall of immune memory by mucosal immunization with a non-toxic recombinant enterotoxin-based chimeric protein.
Gockel CM; Russell MW
Immunology; 2005 Dec; 116(4):477-86. PubMed ID: 16313361
[TBL] [Abstract][Full Text] [Related]
2. Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues.
Toida N; Hajishengallis G; Wu HY; Russell MW
Infect Immun; 1997 Mar; 65(3):909-15. PubMed ID: 9038296
[TBL] [Abstract][Full Text] [Related]
3. Characterization of antigen-presenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxins.
Zhao W; Zhao Z; Russell MW
Mol Oral Microbiol; 2011 Jun; 26(3):200-9. PubMed ID: 21545697
[TBL] [Abstract][Full Text] [Related]
4. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit.
Wu HY; Russell MW
Infect Immun; 1993 Jan; 61(1):314-22. PubMed ID: 8418053
[TBL] [Abstract][Full Text] [Related]
5. Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells.
Martin M; Hajishengallis G; Metzger DJ; Michalek SM; Connell TD; Russell MW
Infect Immun; 2001 Jan; 69(1):252-61. PubMed ID: 11119513
[TBL] [Abstract][Full Text] [Related]
6. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
Huang Y; Hajishengallis G; Michalek SM
Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of liposomes possessing surface-linked recombinant B subunit of cholera toxin as an oral antigen delivery system.
Harokopakis E; Hajishengallis G; Michalek SM
Infect Immun; 1998 Sep; 66(9):4299-304. PubMed ID: 9712781
[TBL] [Abstract][Full Text] [Related]
8. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit.
Russell MW; Wu HY
Infect Immun; 1991 Nov; 59(11):4061-70. PubMed ID: 1937766
[TBL] [Abstract][Full Text] [Related]
9. Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of cholera toxin.
Katz J; Harmon CC; Buckner GP; Richardson GJ; Russell MW; Michalek SM
Infect Immun; 1993 May; 61(5):1964-71. PubMed ID: 8478086
[TBL] [Abstract][Full Text] [Related]
10. Long-term persistence and recall of immune responses in aged mice after mucosal immunization.
Harrod T; Martin M; Russell MW
Oral Microbiol Immunol; 2001 Jun; 16(3):170-7. PubMed ID: 11358539
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of intestinal antigen-presenting cells involved in uptake and processing of a nontoxic recombinant chimeric mucosal immunogen based on cholera toxin using imaging flow cytometry.
Zhao W; Minderman H; Russell MW
Clin Vaccine Immunol; 2014 Jan; 21(1):74-84. PubMed ID: 24197893
[TBL] [Abstract][Full Text] [Related]
12. Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection.
Zhang P; Jespersgaard C; Lamberty-Mallory L; Katz J; Huang Y; Hajishengallis G; Michalek SM
Infect Immun; 2002 Dec; 70(12):6779-87. PubMed ID: 12438353
[TBL] [Abstract][Full Text] [Related]
13. Mucosal and systemic antibody responses after peroral or intranasal immunization: effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant.
Rask C; Fredriksson M; Lindblad M; Czerkinsky C; Holmgren J
APMIS; 2000 Mar; 108(3):178-86. PubMed ID: 10752686
[TBL] [Abstract][Full Text] [Related]
14. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.
Wu HY; Russell MW
Vaccine; 1998; 16(2-3):286-92. PubMed ID: 9607044
[TBL] [Abstract][Full Text] [Related]
15. Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.
Russell MW; Moldoveanu Z; White PL; Sibert GJ; Mestecky J; Michalek S M
Infect Immun; 1996 Apr; 64(4):1272-83. PubMed ID: 8606090
[TBL] [Abstract][Full Text] [Related]
16. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits.
Hajishengallis G; Hollingshead SK; Koga T; Russell MW
J Immunol; 1995 May; 154(9):4322-32. PubMed ID: 7722290
[TBL] [Abstract][Full Text] [Related]
17. Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.
Price GA; Russell MW; Cornelissen CN
Infect Immun; 2005 Jul; 73(7):3945-53. PubMed ID: 15972481
[TBL] [Abstract][Full Text] [Related]
18. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
19. Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.
Shen X; LagergÄrd T; Yang Y; Lindblad M; Fredriksson M; Holmgren J
Infect Immun; 2000 Oct; 68(10):5749-55. PubMed ID: 10992481
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal delivery.
Tinker JK; Yan J; Knippel RJ; Panayiotou P; Cornell KA
Toxins (Basel); 2014 Apr; 6(4):1397-418. PubMed ID: 24759174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]